Article
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Annals of the rheumatic diseases - 1 Jan 2009
Potter C, Hyrich K L, Tracey A, Lunt M, Plant D, Symmons D P M, Thomson W, Worthington J, Emery P, Morgan A W, Wilson A G, Isaacs J, Barton A
Abstract excerpt
OBJECTIVE: To determine whether rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP) antibodies, or carriage of shared epitope (SE) and PTPN22 genetic susceptibility variants predict response to therapy in patients with rheumatoid arthritis (RA) treated with anti-tumour necrosis factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.